Back to Global NewsPublished: 27 Feb 2026Download AppJoin TelegramWhy Merck's Expanded Keytruda Approval Could Flip the Ovarian Cancer Market#Merck#Keytruda#Ovarian Cancer#EU Pharma#Investment#HealthcareDownload AppJoin CommunityShare Article